CMS Says It Will Spend $3.5 Billion On Leqembi, But This Is

Skepticism may be warranted when Medicare says it expects to spend $3.5 billion on the Alzheimer’s disease drug Leqembi.

Related Keywords

United States , American , Eli Lilly , Medpage Todayreports , Xavier Becerra , Clinical Trials On Alzheimer Disease Congress , Medicaid Service Office Of The Actuary , Department Of Health , Journal Of The American Medical Association , Centers For Medicare , Human Services , Leqembi May Be , Medicaid Service Office , American Medical Association , Endpoints News , Human Services Secretary Xavier Becerra , Clinical Trials , Disease Congress , New England Journal , Kkff , Medicare , Leqembi , Biogen , Eisai , Alzheimers Disease , Aduhelm , Cms , Donanemab , Beta Amyloid Plaque ,